Can inflammation reduce hepatic SHBG production and change sex hormone bioavailability?

Inflammation triggers a sophisticated signaling cascade that directly influences hepatic protein synthesis, significantly impacting the regulatory landscape of sex hormones. This interaction is particularly relevant in the context of aging and metabolic health, where chronic low-grade inflammation often intersects with hormonal shifts.

Mechanistic basis of cytokine signaling

Pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β), act as potent inhibitors of sex hormone-binding globulin (SHBG) production in the liver.

• Transcriptional suppression: Research using human hepatocyte models (HepG2) demonstrates that TNF-α and IL-1β downregulate SHBG mRNA expression. This occurs primarily through the inhibition of hepatocyte nuclear factor-4alpha (HNF-4α), a master transcription factor required for SHBG promoter activity.
• Signaling pathways: IL-1β utilizes MEK-1/2 and JNK MAPK signaling pathways to reduce HNF-4α levels. This molecular interference directly translates to lower hepatic synthesis and decreased circulating plasma levels of SHBG.
• Inflammatory feedback: A bidirectional relationship exists where SHBG may also exert anti-inflammatory effects by suppressing the production of IL-6 and TNF-α in macrophages and adipocytes. Consequently, cytokine-driven suppression of SHBG can create a self-perpetuating inflammatory loop.

Impact on hormone bioavailability

The concentration of SHBG is a primary determinant of sex hormone bioavailability, governed by the "free hormone hypothesis."

• Hormone sequestration: SHBG binds testosterone with high affinity. Only the "free" fraction (typically 1–3% of total testosterone) is biologically active and capable of diffusing into target tissues.
• Clinical significance: Changes in SHBG levels shift the equilibrium between bound and unbound hormones. In states of chronic inflammation, the resulting decrease in SHBG leads to a higher percentage of free testosterone initially; however, in a clinical context, this is often accompanied by a decline in total testosterone production, complicating the hormonal profile.
• Metabolic associations: Lower SHBG levels are strongly correlated with inflammatory markers such as C-reactive protein (CRP) and IL-6, particularly in aging populations and those with metabolic syndrome.

Bottom line

Inflammation-related cytokines directly suppress the hepatic synthesis of SHBG by inhibiting key transcription factors. Because SHBG regulates the distribution of sex hormones, these inflammatory signals fundamentally alter the bioavailability of testosterone and estrogens, serving as a critical link between systemic inflammation and endocrine dysfunction.